[Therapeutic use of beta blockers in gastroenterology. Gastrointestinal iatrogenic diseases caused by beta blocker use].
De Simone
M
M
Leonardi
C
C
Carbonetti
M
M
Mazzetti di Pietralata
M
M
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000818:Animals; D001262:Atenolol / Q000009:adverse effects / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007049:Iatrogenic Disease; D007422:Intestines / Q000293:injuries; D010538:Peritonitis / Q000139:chemically induced; D011217:Practolol / Q000009:adverse effects / Q000627:therapeutic use; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use; D011942:Receptors, Adrenergic, alpha / Q000502:physiology; D011943:Receptors, Adrenergic, beta / Q000502:physiology
D000319:Adrenergic beta-Antagonists; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D001262:Atenolol; D011433:Propranolol; D011217:Practolol
Impiego terapeutico dei beta-bloccanti in gastroenterologia. Patologia iatrogena gastroenterologica da impiego di beta-bloccanti.